The star of the agreement, ADEL-Y01, targets a specific type of tau protein, helping to prevent toxic accumulation in the brain while also preserving the function of healthy tau.
The star of the agreement, ADEL-Y01, targets a specific type of tau protein, helping to prevent toxic accumulation in the brain while also preserving the function of healthy tau.